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Abstract
Background: The use of silica coated magnetic nanoparticles as contrast agents has resulted in the production of
highly stable, non-toxic solutions that can be manipulated via an external magnetic field. As a result, the
interaction of these nanocomposites with cells is of vital importance in understanding their behaviour and
biocompatibility. Here we report the preparation, characterisation and potential application of new “two-in-one”
magnetic fluorescent nanocomposites composed of silica-coated magnetite nanoparticles covalently linked to a
porphyrin moiety.
Method: The experiments were performed by administering porphyrin functionalised silica-coated magnetite
nanoparticles to THP-1 cells, a human acute monocytic leukaemia cell line. Cells were cultured in RPMI 1640
medium with 25 mM HEPES supplemented with heat-inactivated foetal bovine serum (FBS).
Results: We have synthesised, characterised and analysed in vitro, a new multimodal (magnetic and fluorescent)
porphyrin magnetic nanoparticle composite (PMNC). Initial co-incubation experiments performed with THP-1
macrophage cells were promising; however the PMNC photobleached under confocal microscopy study. b-
mercaptoethanol (b-ME) was employed to counteract this problem and resulted not only in enhanced
fluorescence emission, but also allowed for elongated imaging and increased exposure times of the PMNC in a
cellular environment.
Conclusion: Our experiments have demonstrated that b-ME visibly enhances the emission intensity. No deleterious
effects to the cells were witnessed upon co-incubation with b-ME alone and no increases in background
fluorescence were recorded. These results should present an interest for further development of in vitro biological
imaging techniques.
Background
Magnetic nanoparticles have been the focus of much
research due to their potential biomedical applications
as both diagnostic tools and therapeutic agents [1,2].
Suspensions of superparamagnetic nanoparticles of
iron oxide are promising magnetic resonance imaging
contrast agents, improving the image quality of anato-
mical structures by altering the relaxation time of the
protons present [3-6]. Magnetic nanoparticles may also
induce heat once subjected to an external magnetic
AC field, opening up the possibility of hyperthermic
cancer treatment [7,8]. Site-specific drug delivery is an
enticing possibility, which may be realised by loading
nano-magnetic carriers with therapeutic agents and
directing them to the site of interest using external
magnetic fields [9,10]. The assembly of a number of
building blocks with different functionalities could pro-
vide a multimodal platform allowing for the combina-
tion of diagnostic imaging and therapeutic capabilities
[11-13]. In particular, nanoscale entities combining
magnetic and fluorescent properties have attracted
much attention. Their potential uses in medicine are
far-reaching including in imaging, bio- and chemo-
sensing, drug delivery and therapy systems. Challenges
remain in their fabrication, which frequently involve
multi-step reactions to prevent the quenching of the
fluorophore. Several synthetic routes have been
reported, including core-shell composites, bilipid layers
between the particle surface and the fluorescent
moiety composites, and use of electrostatic interactions
between stabilizers, magnetic particles and
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fluorophores [14-18]. The surface chemistry of these
composite materials plays a crucial role in cellular
uptake. For example magnetic nanoparticles, functiona-
lised with a chitosan-labelled fluorescein isothiocyanate
derivative, have shown uptake by human hepatoma
cells via charged interactions [19]. Interesting multi-
functional nanocomposites comprising of silver and
iron oxide nanoparticles embedded in a silica shell,
together with a Raman reporter molecule have been
published by Murphy et. al. [20]. The introduction of a
rhodamine moiety to the silica surface gives the com-
posite a broad range of potential applications due to
its magnetic, light scattering, SERS and fluorescent
properties. Trapping a rhodamine dye within a silica
matrix during the formation of a shell surrounding the
magnetite nanoparticles has also led to the formation
of magnetic-fluorescent nanocomposites [21,22]. In
addition superparamagnetic iron oxide nanoparticles
(SPION) are of particular interest for targeted cancer
therapy. Tumour-targeted hyperthermia using super-
paramagnetic, biocompatible, and nanosized delivery
vehicles would allow patients to receive increased
treatment dosages while minimizing side effects. Some
recent research investigating SPION was also dedicated
to the early detection of cancer, diabetes, and athero-
sclerosis [23-25].
Here we report the preparation, characterisation and
application of new “two-in-one” magnetic-fluorescent
nanocomposites composed of silica-coated magnetite
nanoparticles, which are covalently linked to a porphyrin
moiety.
Results and discussion
Synthesis and characterisation of the porphyrin-
magnetite nanocomposite (PMNC)
Magnetite nanoparticles have been produced by a pre-
viously reported co-precipitation method (see Materials
and Methods) [26,27]. Application of a silica layer was
achieved by following a method reported by Philips and
co-workers [28]. Briefly, a colloidal solution of magnetite
nanoparticles in tetramethylammonium hydroxide
(TMAH) was treated with sodium silicate in order to
deposit a thin layer of silica on the surface of the oxide
particles (Figure 1). In a separate step, a carboxylic acid
protoporphyrin (protoporphyrin IX) was reacted with 3-
aminopropyltriethoxysilane (3-APTES) under inert con-
ditions in the presence of the carbodiimide coupling
agent (EDCI) to form an amide bond. This modified
porphyrin was then reacted with the silica coated parti-
cles, to form a stable colloidal suspension. In this case
the silica shell was necessary to provide an effective bar-
rier between the particle core and the fluorescent por-
phyrin, preventing the risk of quenching.
Elemental analysis of the PMNC shows a content of C
- 9.31, H - 1.21 and N - 1.51%. This clearly confirms
the presence of conjugated porphyrin molecules at the
surface of nanoparticles.
The presence of the porphyrin on the surface of the
silica-coated magnetite nanoparticles was also confirmed
by Fourier Transform Infrared Infra-red (FTIR) spectro-
scopy (Figure 2). FTIR spectra of the silica coated mag-
netite nanoparticles before and after reaction with the
protoporphyrin were recorded in KBr. The silica coated
Figure 1 PMNC synthesis: Preparation of the PMNC using a base catalyzed condensation reaction to attach a 3-APTS modified
protoporphyrin IX to silica coated magnetite nanoparticles. (i) A thin silica layer is introduced on the magnetite nanoparticle surface by
employing TMAH and sodium silicate. (ii) An amide coupling reaction is performed between the carboxylic acid groups of protoporphyrin IX and
3-APTS. (iii) A base catalysed hydrolysis between the modified porphyrin and the silica coated magnetite nanoparticles results in a magnetic-
fluorescent nanocomposite.
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particles (shown in heavy black circles above) have
stretches at 579, 1087, 1625 and 3286 cm-1 correspond-
ing to the Fe-O, Si-O-Si, and water stretches respec-
tively. The stretch found at 947 cm-1 is due to the
presence of Fe-O-Si bonds in the sample. For the nano-
composite material, again Fe-O and water stretches are
found at 579, 1621 and 3286 cm-1 respectively. The Fe-
O-Si stretch is this time masked by the NH wagging
from the porphyrin centred at 901 cm-1. NH stretches
are found at 1473 cm-1. Aromatic and aliphatic stretches
associated with the porphyrin are found at 2500 and
2945 cm-1 respectively. FTIR spectra (Figure 2) of the
porphyrin nanocomposite material showed stretches for
NH due to the presence of the porphyrin at 901 and
1473 cm-1. Aromatic and aliphatic stretches associated
with the porphyrin are found at 2500 and 2945 cm-1
respectively. A core-shell-like morphology is apparent
from TEM images taken of the silica coated nanoparti-
cles. The average primary particle size is calculated to
be 9.3 ± 1 nm. The silica coating on the particles has an
average thickness of 3 nm, however upon reaction with
the 3-APTES modified protoporphyrin IX, the coating
thickness is found to slightly increase to 4 nm.
Absorbance spectra of the original porphyrin and the
PMNC were taken in tetrahydrofuran, THF (Figure 3).
Peaks at 406, 505, 538, 577 and 632 nm were observed
for a solution of porphyrin. Emission (lex, 406 nm)
and excitation spectra (lem was 633 nm) have also
been recorded, with significant broadening witnessed
for the PMNC when compared to the original por-
phyrin. This can be attributed to the scattering of the
incoming light by the PMNC suspension, but gives
further indication of the binding of the porphyrin to
the nanoparticle surface.
Dynamic Light Scattering (DLS) studies of silica
coated magnetite nanoparticles have shown a very broad
size distribution with an average hydrodynamic diameter
of 131 nm, due to aggregation of nanoparticles. How-
ever, silica coated porphyrin functionalised magnetic
nanoparticles have demonstrated relatively narrow dis-
tribution with an average hydrodynamic diameter of 818
nm (Figure 4).
TEM images taken of the silica coated nanoparticles
reveal the presence of a core-shell structure (Figure 5).
The silane coating on the particles has an average thick-
ness of 3 nm and the particles are found to aggregate in
group of approximately ten particles. Upon reaction
with the 3-aminopropyltriethoxysilane modified proto-
porphyrin, the coating thickness is found to slightly
increase to 4 nm.
Magnetisation measurements of original non-coated
magnetite nanoparticles, silica coated magnetite nano-
particles and silica-coated porphyrin functionalised mag-
netite nanoparticles as expected, have shown a gradual
reduction in saturation magnetisation values (58.4 Am2/
kg for pristine magnetite nanoparticles, 35.2 Am2/kg for
silica coated magnetite nanoparticles and 27.5 Am2/kg
for the corresponding porphyrin conjugates) with an
Figure 2 FTIR spectra of the silica coated magnetite
nanoparticles before and after reaction with the
protoporphyrin were recorded in KBr. The spectrum of silica
coated particles is shown in heavy black circles above.
Figure 3 Optical characterisation of the PMNC: (a) Absorbance
spectra of original protoporphyrin IX (solid line) [1.57 × 10-6 M] and
PMNC (dotted line) [100 μl PMNC in 3 ml THF]. (b) Normalised
emission and excitation spectra of original porphyrin (solid line)
[5.23 × 10-7 M] and PMNC (dotted line) [100 μl PMNC in 3 ml with
THF]. lem = 633 nm, lex = 406 nm.
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increasing amount of non-magnetic material, i.e. silica
and porphyrin conjugates (Figure 6).
The combination of both magnetic and fluorescent
properties in one nanocomposite can provide additional
benefits. For example, these nanocomposites could serve
as multimodal assays for in vitro- and vivo- bioimaging
applications such as MRI and fluorescence microscopy.
They can also be used as bimodal agents for anticancer
therapy, encompassing photodynamic and hyperthermic
capabilities. Fluorescent-magnetic nanocomposites may
also be utilised as a multimodal diagnostic and thera-
peutic tool, which could be used, for example, to iden-
tify, diagnose and simultaneously treat various diseases.
Other potential exciting applications of these
Figure 4 DLS results for suspensions of (a) silica coated magnetite nanoparticles and (b) silica-coated porphyrin functionalised
magnetite nanoparticles.
Figure 5 TEM images (a) silane coated nanoparticles and (b) after reaction with protoporphyrin and (c) HR TEM image of the
porphyrin coated magnetite nanoparticle.
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nanocomposites include cell tracking, cytometry and
magnetic separation, which could be easily controlled
and monitored using fluorescent microscopy and MRI.
Cell culture experiments
Previously, the cytotoxic effects of poly(ethylene glycol)-
co-fumarate (PEGF)-coated magnetite nanoparticles and
their capability for changing cell culture medium com-
positions have been investigated. The primary mouse
connective tissue cells (L929) were used for this pur-
pose. Toxicity levels and changes in the cell culture
medium compositions were determined using the MTT
assay and a UV/vis spectroscopy method, respectively.
As compared to the conventional method, a more reli-
able method for determining the cytotoxicity of nano-
particles for in vitro applications is found [29]. It also
has been demonstrated that the incorporation of antic-
ancer drugs such paclitaxel into PLGA nanoparticles in
nanoparticles strongly enhances the cytotoxic effect of
the drug as compared to Taxol, this effect being more
relevant for prolonged incubation times [30,31].
In our studies THP-1 (human acute monocytic leu-
kaemia) cells were cultured in the presence of phorbol
12-myristate 13-acetate (PMA) for 3 days to initiate
monocyte to macrophage differentiation. Half the
volume of complete culture media was then replaced
with serum free media to “starve” the cells, allowing
for an enhanced up-take of the PMNC. Figure 7 shows
a confocal image of a THP-1 cell after incubation with
the PMNC for 3 hours. The particles are localised in
the cytoplasm, as detected by confocal imaging, and
the image is representative of the broader cell
population.
During the experiments we have found that following
an exposure time of only 482 ms, the PMNC begins to
photobleach, and after only 4 seconds, the fluorescence
intensity has greatly decreased (Figure 8). This process
is highly undesirable as it makes the generation, capture
and interpretation of the image extremely difficult and
does not allow for a full examination of the cells to
determine precisely the nature of the nanocomposite
localisation.
Figure 6 Magnetisation curves of original non-coated (a) magnetitite nanoparticles, (b) silica coated magnetite nanoparticles and (c)
silica-coated porphyrin functionalised magnetite nanoparticles.
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In an effort to alleviate the photobleaching, b-mercap-
toethanol (b-ME) was employed to counteract this pro-
blem, and was added once the cells were fixed. Control
experiments performed with THP-1 cells in the pre-
sence of b-ME show that no deleterious effects are wit-
nessed and the cells retain their size, shape and
membrane integrity (Figure 9). Addition of b-ME to
cells cultured with the PMNC prevented this photo-
bleaching effect and resulted in a stronger fluorescence
signal compared to those without b-ME (see Figures 9
and 10). Following the same cell preparation and co-
incubation times, we can clearly see not only an
increased resistance to photobleaching, but the addition
of b-ME also resulted in an enhanced and extended
fluorescence emission. This improved photostability is
due to the b-ME acting as a scavenger for singlet oxy-
gen, which is traditionally attributed to the photobleach-
ing of porphyrin based dyes.
To further exemplify the enhancement in fluorescent
emission intensity due to the presence of the b-ME,
pseudocoloured images of the cells were generated (Fig-
ure 10). The pseudocoloured images reflect the inte-
grated fluorescence intensity levels across the
cytoplasmic and nuclear compartments of the THP-1
cells. Background fluorescence appears blue and predo-
minates for those cells without any nanocomposite
added (panels 10 c and d) but also for cells cultured
with the PMNC alone (panel 10 a). A dramatic change
is witnessed upon addition of the b-ME (panel 10 b).
The PMNC is no longer quenched so dramatically and
readily emits with substantial emission increases
recorded after 4 seconds.
To verify that the increased emission is due to the
PMNC and not as a result of increased cellular auto-
fluorescence, control experiments were also conducted.
Panels 10 c and d show untreated and b-ME treated
Figure 7 THP-1 cells incubated with the PMNC: THP-1 cells incubated with the PMNC for 3 hours. (a) confocal (b) bright field and (c)
composite images of a THP-1 cell with internalised PMNC (lex = 540 nm).
Figure 8 Transmitted light microscopic images of (a) untreated THP-1 cells and (b) THP-1 cells in the presence of b-ME. Note scale bar
equals 10 μm. No deleterious effects to the cell size, shape or membrane integrity are noted.
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Figure 9 Evaluation of PMNC emission intensities: comparison of the PMNC emission intensity when incubated with THP-1 cells with
(bottom panel) and without (top panel) b-ME. (a) Bright field and (b, c) fluorescence images of the PMNC and the THP-1 cells without b-ME
(d) Bright field and (e, f) fluorescence images of the PMNC and the THP-1 cells with b-ME. Note: (a, b, d, e) images taken at t = 0 seconds, (c, f)
taken at t = 4 seconds, exposure time for each image is 482 ms and (lex = 540 nm).
Figure 10 Pseudocoloured fluorescence images: pseudocolored images of (a) THP-1 cells incubated with the PMNC (b) THP-1 cells
incubated with PMNC in the presence of b-ME (c) untreated THP-1 cells and (d) cells in the presence of b-ME alone. Transition colour
from blue to red indicates an increase in fluorescence intensity.
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THP-1 cells respectively and clearly illustrate that the
level of background fluorescence remains constant
throughout the experiment. This proves that autofluor-
escence does not contribute to the enhanced levels of
emission witnessed for those cells cultured with the
PMNC in the presence of b-ME.
In order to probe the maximum fluorescence intensity
of the PMNC as a function of excitation wavelength and
also to monitor the fluorescence intensity across the cell
compartments, a series of fluorescence images were
recorded over varying wavelengths together with emis-
sion spectral mapping of the cell. Cells were cultured
with the PMNC with and without the presence of b-
ME. Lambda scans recorded of cells cultured without b-
ME show a noted decrease in brightness and the com-
bined image is noticeably lower in fluorescence inten-
sity. This is shown quantitatively in the fluorescence
emission spectra, which show an almost 20% decrease in
fluorescence intensity (Figures 11 and 12).
Finally, to compare the results a series of similar con-
trol experiments have been performed on “non-starved”
THP-1 cells, which were incubated with serum free
media. Confocal and composite images of the cells incu-
bated with fluorescent magnetic nanoparticles have been
taken at different periods of time 24 hrs, 48 hrs and 5
days (Figures 13, 14, 15 and 16). The results have
demonstrated that there was no cellular uptake of the
fluorescent nanocomposites but only binding of the
PMNC to the outer cell membranes.
Conclusion
In summary, we have successfully synthesised a new
two-in-one magnetic-fluorescent nanocomposite. Initial
co-incubation experiments performed with THP-1
macrophage cells in the presence of the PMNC showed
a distinct photobleaching of the porphyrin upon expo-
sure to light under a fluorescent microscope. This
bleaching was counteracted by the addition of b-ME
which resulted not only in increased fluorescence inten-
sity levels, but also allowed for enhanced imaging and
increased exposure times of the PMNC in a cellular
environment. This was further corroborated by pseudo-
fluorescent images which show how b-ME visibly
enhances the emission intensity. Furthermore, no dele-
terious effects to the cells were witnessed upon co-incu-
bation with b-ME alone and no increases in background
fluorescence were recorded. We believe that this
research should present an interest for further develop-
ment of and new multimodal nanoparticulate agents for
in vitro biological imaging.
Materials and methods
Synthesis
Synthesis of nanoparticles and coating with silica
Magnetite nanoparticles were prepared according to the
previously reported coprecipitation method. Stock solu-
tions of 25 mL of each of 1 M FeCl3.6H2O (6.56 g,
0.024 mol), 0.5 M FeCl2.4H2O (2.48 g, 0.012 mol), and
0.4 M HCl were made up with Millipore water. NaOH
Figure 11 Lambda scan of THP-1 cells and PMNC taken using a Zeiss LSM Meta-510 confocal microscope. (a) Series of images recorded
for various wavelength ranges between 545-748 nm. (b) Merge of all images from (a) showing the slight variations in l across the sample. (c)
Shows the spectra for each of the region of interest (ROI) in b. Excitation wavelength 405 nm.
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solution (0.5 M, 250 mL) was heated to 80°C and the
iron solution was added dropwise. After one hour of
stirring (at 1200 rpm) with heat, the black magnetic
nanoparticles were washed with Millipore water (5 × 20
mL) until neutral. A sample of the nanoparticles (1 g)
was dispersed in tetramethylammonium hydroxide (30
mL) and made up to 570 mL with Millipore water.
0.58% activated sodium silicate (430 mL) was added to
the nanoparticle suspension. The sodium silicate was
activated by passing through a regenerated cation
exchange resin. After two hours stirring, the magnetic
fluid was transferred into dialysis tubing and dialysed
against Millipore water brought to pH 10 by the addi-
tion of tetramethylammonium hydroxide. The dialysis
tubing was prepared by boiling tubing of the required
length in 2% (w/v) sodium bicarbonate (100 mL) and 1
mM EDTA (100 mL) at pH 8.0 for ten minutes. The
tubing was rinsed with Millipore water then boiled for
ten minutes in 1 mM EDTA followed by Millipore
water rinsing. After 24 hour dialysis, the solution was
brought to pH 8.0 by the addition of dilute HCl. The
particles were washed and finally dried under vacuum.
Modification of protoporphyrin and attachment to
magnetic nanoparticles
Protoporphyrin IX (0.1 g; 0.177 mmol) was dissolved in
dry THF (20 mL). N-(3-Dimethylaminopropyl)-N’-ethyl-
carbodiimide (0.17 g; 0.887 mmol) was added to’ the
stirring deep red solution and the reaction mixture was
stirred (at 1200 rpm) for 3 hours at 0°C. The reaction
was carried out in the dark to prevent any possible
Figure 12 Lambda scan of THP-1 cells and PMNC in the presence of b-ME taken using Zeiss LSM Meta-510 confocal microscope. (a)
Series of images recorded for various wavelength ranges between 545-748 nm. (b) Merging of all images from (a) showing the variations in l
across the sample. (c) Emission spectra for each point mapped in (b).
Figure 13 (a) Confocal, (b) composite and (c) bright field images showing the localization patterns of the PMNC in live THP-1
macrophage cells following a 24 hour co-incubation period. Panel (a) shows the clear fluorescence labelling of the outer cell membranes
by the nanoparticles. The PMNC did not penetrate the cell membrane as these cells were not incubated with serum free media.
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photobleaching of the porphryin. 3-Aminopropyl-
triethoxysilane (83 μL; 0.355 mmol) in 2 mL dry THF
was added to the porphyrin solution at 0°C. The reac-
tion mixture was brought to room temperature and
allowed to react overnight. Silica coated magnetite nano-
particles (0.1 g) were added to the reaction vessel with
triethylamine (300 μL) and allowed to react for 24
hours. The mixture was centrifuged and the particles
were washed with bench THF (5 × 40 mL) to remove
any un-reacted porphyrin or unwanted side-products.
The particles of PMNC were finally washed with water.
Elemental analysis, found: C - 9.31, H - 1.21, N - 1.51.
Tissue culture
THP-1 cells, a human acute monocytic leukaemia cell
line, were obtained from the American Type Culture
Collection (ATCC, LGC Promochem, U.K.). Cells were
cultured in RPMI 1640 medium with 25 mM HEPES
(Gibco, Invitrogen Ltd., Ireland), supplemented with
heat-inactivated foetal bovine serum (FBS) (9%), 200
mM/ml L-glutamine (0.9%, 1.8 mM/ml), 10,000 U/ml
penicillin (0.9%, 90 U/ml), and 10 mg/ml streptomycin
(0.9%, 0.09 mg/ml) at 37°C and 5% CO2 content.
Cell assays
THP-1 cells were seeded into an 8-well chamber slide,
with a final concentration of 2 × 104 cells per well. To
induce monocyte to macrophage differentiation, THP-1
cells were cultured in 100 ng/ml phorbol 12-myristate
13-acetate (PMA) for 3 days at 37°C in 5% CO2. Half
the volume of media was then replaced by serum free
media (RPMI 1640 with 25 mM HEPES) and the cells
were incubated for 2 hours at 37°C in 5% CO2. The
PMNC was then added at a final concentration of 0.25
mg/ml. To another well, b-mercaptoethanol b-ME was
added. A control experiment with the Protoporphyrin
IX dissolved in mixture of water and tetrahydrofuran
(THF) was carried out in parallel using the same condi-
tions, with a final porphyrin concentration of 0.119 mg/
ml. Fluorescence images were recorded using a Nikon
TE3000 inverted microscope. Confocal imges were col-
lected using a 63× oil immersion objective, laser
Figure 14 (a) Confocal, (b) composite and (c) bright field images of THP-1 macrophage exposed to the PMNC for 24 hours. Cells were
incubated with serum free media for 2 hours.
Figure 15 (a) Confocal, (b) composite and (c) bright field images of THP-1 macrophage cells exposed to the PMNC for 48 hours. Cells
were incubated with serum free media for 2 hours.
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excitation 561 nm and LP 575 nm filter on a Zeiss LSM
Meta-510 confocal microscope.
Spectroscopy
UV-Vis absorption spectra were recorded using a Cary
50 UV-Vis spectrophotometer. Fluorescence measure-
ments were performed on a Cary Eclipse spectrophot-
ometer. FT-IR spectra were recorded KBr using a Perkin
Elmer Spectrum One FT-IR spectrophotometer. TEM
images were taken on a Hitachi H-7000 at a beam vol-
tage of 100 kV.
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